This information collection request is approved as submitted, except that prior to distribution, FDA will put the legally-required PRA burden statement in the front of the guidance and the OMB number will be displayed.
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
09/30/2010
36 Months From Approved
900
0
0
900
0
0
0
0
0
A draft guidance titled Guidance for Administrative Procedures for CLIA Categorization was released for coment August 14,2000. The document describes procedures FDA will use to assign the complexity category to a device and includes information that manufacturers should send to FDA in cases where the complexity categorization is determined separate from the premarket submission.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.